Peer Recovery Support for Opioid Use Disorder Treatment Retention

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pennsylvania
Study ID
NCT07620171
Status
Enrolling By Invitation

Conditions

  • Buprenorphine
  • Opioid Use Disorder
  • Peer Recovery Coaching
  • Peer Recovery Supporters
  • Primary Care

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Peer Support — BEHAVIORAL
    Peer recovery support services delivered by trained, certified peers with lived experience of opioid use disorder, added to standard medication-assisted treatment (buprenorphine) in a primary care setting. Peer services are structured around three stages of OUD treatment (initial engagement, early treatment, and stable treatment) with contact intensity tailored to dropout risk at each stage (approximately 2 contact hours/week during initial engagement). Contact modalities include in-office meetings, phone calls, texts, and appointment reminders. Peers are supervised and integrated as full members of the clinical care team. The intervention was developed with input from OUD, peer, and implementation experts and informed by qualitative and survey data from Philadelphia-region OUD treatment programs. Caseload: approximately 15 patients per peer. Duration: 180 days.

Study Details

The goal of this clinical trial is to learn whether adding peer recovery support services to standard opioid use disorder (OUD) treatment in primary care helps patients stay in treatment longer. The main question it seeks to answer is whether it is feasible to deliver a peer recovery support intervention alongside medication-assisted treatment (buprenorphine) in a Philadelphia primary care clinic. Participants will receive standard OUD treatment (buprenorphine) combined with peer recovery support services for 180 days. They will attend study visits at baseline, weekly for the first 2 weeks, then every 2 weeks, then monthly, and complete assessments about substance use, medication adherence, self-efficacy, resilience, and coping. Participants will also take part in brief periodic interviews about their experience with peer support.

Key Dates

Start date
Jan 9, 2026
Status verified
May 2026
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Peer Support

Primary Outcome Measure

OUD treatment retention [ Time Frame: 180 days ]

Locations (1)

FacilityCityStateZIPSite coordinators
Penn Family MedicinePhiladelphiaPennsylvania19104-

Find similar trials in Philadelphia, PA

By research site
Penn Family Medicine· Philadelphia, PA

Related Studies